recent
simmon
et
al
report
new
mechan
sar
viru
entri
target
cell
identifi
effici
inhibitor
ctslmedit
substrat
cleavag
ic
nmoll
base
molecul
fingerprint
search
method
natur
molecul
found
tradit
chines
medicin
databas
tcmd
molecular
simul
indic
compound
deriv
chines
medicin
herb
therapeut
efficaci
human
bodi
reliev
cough
remov
phlegm
reliev
asthma
highest
bind
energi
receptor
also
good
match
geometr
conform
observ
dock
studi
van
der
waal
interact
made
substanti
contribut
affin
receptor
activ
pocket
larg
suitabl
accordingli
might
possibl
becom
promis
lead
compound
ctsl
inhibit
sar
therapi
sever
acut
respiratori
syndrom
sar
acut
respiratori
diseas
caus
newli
identifi
coronaviru
sarscov
rota
et
al
result
zoonosi
highli
relat
anim
coronaviru
guan
et
al
continu
potenti
zoonot
transmiss
event
lead
reintroduct
sarscov
human
popul
previou
studi
drug
discoveri
sar
mainli
target
proteinas
name
main
proteinas
cov
pro
sarscoronaviru
key
step
transcript
replic
sarscov
chou
et
al
yang
et
al
chou
anand
et
al
suggest
inhibitor
rhinoviru
cov
pro
could
serv
start
point
antisar
drug
base
three
dimension
structur
proteinas
owe
fit
problem
bind
pocket
sar
cov
pro
chou
et
al
suggest
deriv
better
start
point
du
et
al
develop
promis
approach
find
polypeptid
inhibitor
sarscov
pro
search
cleavag
site
protein
sar
enzym
far
effort
discov
drug
sar
associ
proteas
inhibitor
target
sar
cov
pro
recent
new
mechan
entri
sar
cov
target
cell
report
simmon
et
al
hypothes
cellular
factor
sensit
ammonium
chlorid
phdepend
endosom
protein
may
great
effect
mediat
sarscov
entri
studi
requir
proteas
activ
viral
infect
effect
proteas
inhibitor
sarscov
infect
examin
studi
result
consist
model
sarscov
employ
uniqu
threestep
procedur
membran
fusion
involv
receptor
bind
induc
conform
chang
glycoprotein
follow
cathepsin
l
ctsl
proteolysi
activ
membran
fusion
within
endosom
new
progress
provid
altern
target
cathepsin
l
drug
design
sar
highli
throughput
screen
librari
pharmacolog
activ
compound
perform
simmon
et
al
simmon
et
al
identifi
effici
inhibitor
ctslmedit
substrat
cleavag
high
bioactiv
nmoll
research
result
demonstr
inhibit
endosom
proteas
activ
sar
viru
enter
process
viru
target
cell
therefor
serv
promis
templat
fusion
inhibitor
design
target
ctsl
studi
use
templat
databas
search
base
ctsl
discoveri
natur
product
drug
candid
chines
tradit
herb
medicin
newli
develop
databas
tradit
chines
medicin
databas
tcmd
zhou
et
al
use
databas
search
part
research
project
modern
chines
tradit
medicin
find
novel
activ
herb
compound
lowtox
use
advanc
drug
design
techniqu
cathepsin
l
one
major
cystein
proteas
gener
found
throughout
mammalian
cell
type
believ
primarili
function
normal
protein
breakdown
mari
mcgrath
cathepsin
l
also
implic
number
diseas
process
bone
resorpt
tumor
metastas
kakegawa
newli
found
function
cathepsin
l
proteolysi
activ
membran
fusion
sarscov
infect
simmon
et
al
potent
select
inhibitor
cystein
proteas
expect
good
candid
therapeut
agent
sar
structur
cathepsin
l
pdb
code
share
common
fold
pattern
papainlik
cystein
proteas
guncar
et
al
structur
consist
two
domain
left
l
domain
right
r
domain
reminisc
close
book
spine
front
domain
separ
top
vshape
activ
site
cleft
middl
residu
one
domain
form
catalyt
dyad
enzym
fig
chemic
structur
jeffrey
et
al
aminotermin
block
dipeptid
aldehyd
display
fig
employ
inhibitor
calpain
protect
rat
erythrocyt
membran
associ
cytoskelet
protein
proteolyt
degrad
mm
shujaath
et
al
also
inhibit
process
jeffrey
et
al
assay
result
simmon
et
al
simmon
et
al
suggest
also
inhibit
ctslmedit
substrat
cleavag
nmoll
sar
viru
entri
therefor
may
becom
initi
potent
candid
antivir
inhibitor
sarscov
structur
bioinformat
chou
appli
time
deriv
structur
function
import
protein
see
eg
chou
c
help
understand
action
mechan
see
eg
virtual
screen
find
natur
inhibitor
chou
et
al
chou
howe
chou
stimul
cours
drug
discoveri
see
eg
chou
e
wei
et
al
studi
approach
structur
bioinformat
use
find
inhibitor
sar
therapi
first
step
similar
search
comput
fingerprint
molecul
molecular
databas
repres
set
featur
deriv
molecular
structur
molecular
featur
calcul
base
topolog
chemic
graph
conform
molecul
express
follow
equat
u
fisaromat
hasr
hasc
haso
hass
hasp
hashalogeng
eq
notat
isaromat
repres
aromat
ring
hasr
satur
ring
hasc
haso
hass
hasp
hashalogen
repres
number
carbon
nitrogen
oxygen
sulfur
phosphoru
halogen
respect
featur
eq
form
subset
u
term
eq
take
valu
therefor
total
possibl
fingerprint
studi
macss
structur
key
sheridan
et
al
bron
martin
use
calcul
fingerprint
natur
product
molecul
databas
second
step
metric
use
compar
fingerprint
templat
studi
metric
tanimoto
coeffici
use
number
mean
maxim
dissimilar
mean
maxim
similar
tanimoto
coeffici
defin
follow
equat
denot
number
featur
fingerprint
b
number
featur
fingerprint
b
ab
denot
number
common
featur
possess
b
comput
dock
oper
use
vehicl
investig
molecular
bind
interact
see
eg
zhou
troy
b
well
known
dock
program
dock
ewe
et
al
use
studi
mpi
parallel
exhaust
orient
search
gbsa
solvat
score
chemicalpharmacophor
screen
kuntz
et
al
calcul
bind
energi
dock
program
perform
use
amber
forc
field
e
total
bind
energi
ligand
receptor
e
vdw
van
der
waal
interact
energi
e
ele
electrostat
interact
energi
calcul
ligand
molecul
flexibl
receptor
rigid
bind
energi
score
base
e
total
valu
databas
search
total
compound
initi
overlap
found
tcmd
natur
product
molecul
search
conduct
use
templat
molecul
base
molecular
similar
describ
section
molecul
filtrat
accord
drug
discoveri
rule
lipinski
et
al
compound
delet
molecular
structur
compound
shown
fig
satisfi
rule
dock
calcul
perform
dock
program
use
forc
field
amino
acid
residu
within
involv
ligand
flexibl
receptor
rigid
bind
energi
favor
conform
activ
pocket
ctsl
molecul
templat
comput
bind
energi
rank
tabl
shown
tabl
two
molecul
mol
higher
score
dock
bind
energi
even
bigger
therefor
possibl
inhibitor
candid
cathepsin
l
compound
see
fig
chines
medicin
herb
aurantiamid
acet
deriv
fig
align
two
ligand
color
chain
type
red
green
repres
respect
b
align
two
ligand
color
pharmacophor
type
white
hydrogen
bond
donor
cyan
hydrogen
bond
receptor
dark
green
hydrophob
atom
respect
artemisia
annua
zhou
et
al
herb
medicin
therapeut
efficaci
human
bodi
antitrach
reliev
cough
remov
phlegm
reliev
asthma
sheng
et
al
flexibl
align
two
ligand
perform
base
set
predetermin
featur
order
find
common
featur
two
ligand
share
shape
log
p
octanolwat
valu
aromat
group
hydrogen
bond
donor
acceptor
figur
b
show
flexibl
align
two
ligand
color
accord
pharmacophor
type
chain
type
color
use
pharmacophor
follow
white
hydrogen
bond
donor
cyan
hydrogen
bond
receptor
dark
green
hydrophob
atom
shown
fig
two
ligand
highli
chemic
similar
especi
hydrophob
side
aromat
group
hydrogen
bond
donor
acceptor
carbonyl
amidogen
ligandreceptor
dock
calcul
favor
conform
ligand
select
conform
lower
energi
shown
fig
hydrogen
bond
suppos
make
import
contribut
interact
ligand
receptor
see
eg
chou
et
al
chou
et
al
chou
e
dock
result
indic
two
hydrogen
bond
ligand
receptor
figur
show
hydrogen
bond
ligand
one
hydrogen
bond
carbonyl
oxygen
molecular
surfac
render
pocket
attribut
constitu
pocket
defin
residu
within
distanc
ligand
green
hydrophob
blue
hydrophil
red
repres
expos
area
respect
interpret
refer
color
figur
reader
refer
web
version
paper
wwwspringerlinkcom
ligand
h
n
anoth
carbonyl
oxygen
ligand
h
figur
show
hydrogen
bond
interact
ligand
three
hbond
first
hbond
carbonyl
oxygen
ligand
h
second
h
n
carbonyl
oxygen
receptor
last
anoth
carbonyl
oxygen
ligand
h
n
shown
tabl
van
der
waal
interact
energi
make
largest
proport
affin
mean
contribut
van
der
waal
interact
key
factor
determin
bind
energi
figur
plot
molecular
surfac
residu
close
ligand
constitu
activ
pocket
chou
et
al
defin
residu
within
distanc
ligand
surfac
render
pocket
attribut
green
hydrophob
blue
hydrophil
red
expos
surfac
respect
shown
fig
better
match
hydrophob
area
activ
pocket
especi
two
hydrophob
aromat
ring
embed
activ
pocket
left
domain
matchabl
indic
left
pocket
space
may
larg
observ
indic
hydrophob
domain
receptor
need
bigger
hydrophob
group
find
would
help
futur
ration
drug
design
combin
tradit
chines
medicin
databas
tcmd
modern
three
dimension
drug
design
techniqu
provid
power
tool
new
drug
discoveri
may
find
natur
product
drug
high
effici
lower
toxic
newli
identifi
proteinas
ctsl
import
target
drug
design
therapeut
intervent
sarscov
infect
function
ctsl
membran
fusion
step
inhibitor
ctsl
may
prevent
viru
enter
target
cell
therefor
may
better
target
sarscov
pro
eleven
chines
herb
compound
screen
tcmd
base
structur
templat
among
highest
similar
lowest
bind
energi
compound
chemic
name
aurantiamid
acet
deriv
chines
medicin
herb
artemisia
annua
zhou
et
al
plant
known
herb
medicin
mani
therapeut
efficaci
antitrach
reliev
cough
remov
phlegm
reliev
asthma
sheng
et
al
therefor
hope
drug
candid
sar
